open access

Vol 64, No 12 (2006)
Other
Published online: 2006-12-21
Submitted: 2012-12-28
Get Citation

Original article
Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome

Michał Chyrchel, Tomasz Rakowski, Łukasz Rzeszutko, Jacek Legutko, Artur Dziewierz, Jacek S. Dubiel, Dariusz Dudek
Kardiol Pol 2006;64(12):1357-1362.

open access

Vol 64, No 12 (2006)
Other
Published online: 2006-12-21
Submitted: 2012-12-28

Abstract

Introduction: Statins given after acute coronary syndrome without ST elevation (NSTE-ACS) reduce the incidence of major adverse cardiac events (MACE) in long-term follow-up. Aim: To evaluate the effects of high-dose statin administered in patients with NSTE ACS and increased CRP level prior to percutaneous coronary intervention (PCI) on the incidence of MACE in long-term follow-up. Methods: The study involved 140 consecutive patients with NSTE ACS and increased CRP level at baseline. Patients from group A (n=54) did not receive statin before PCI, whereas subjects in group B (n=86) were given 80 mg of atorvastatin. Patients in both groups received typical cardiological therapy including aspirin, thienopyridine and low molecular weight heparin. After PCI all patients received 40 mg of atorvastatin. Incidence of MACE (death, myocardial infarction (MI), re-PCI) during long-term follow-up was evaluated in both groups. Results: Study groups did not differ with respect to demographic parameters and rate of ischaemic heart disease risk factors. Also, no differences occurred regarding CRP level (group A vs. B: hsCRP 10.8±1.8 mg/l vs. 8.2±2.8 mg/l; p=NS) and TIMI Risk Score (group A vs. B: 4.3±0.71 vs. 4.37±0.79; p=NS). During long-term follow-up the incidence of MI (9.25% vs. 1.2%, p=0.03), composite endpoint: death + MI (14.8% vs. 2.32%, p=0.013) and death + MI + re PCI (25.9% vs. 8.1%, p=0.006) was significantly higher in group A than group B. Conclusions: Administration of high-dose statin in NSTE ACS patients before PCI was associated with significant reduction of MACE in long-term follow-up. This effect was observed despite the same therapy given after PCI.

Abstract

Introduction: Statins given after acute coronary syndrome without ST elevation (NSTE-ACS) reduce the incidence of major adverse cardiac events (MACE) in long-term follow-up. Aim: To evaluate the effects of high-dose statin administered in patients with NSTE ACS and increased CRP level prior to percutaneous coronary intervention (PCI) on the incidence of MACE in long-term follow-up. Methods: The study involved 140 consecutive patients with NSTE ACS and increased CRP level at baseline. Patients from group A (n=54) did not receive statin before PCI, whereas subjects in group B (n=86) were given 80 mg of atorvastatin. Patients in both groups received typical cardiological therapy including aspirin, thienopyridine and low molecular weight heparin. After PCI all patients received 40 mg of atorvastatin. Incidence of MACE (death, myocardial infarction (MI), re-PCI) during long-term follow-up was evaluated in both groups. Results: Study groups did not differ with respect to demographic parameters and rate of ischaemic heart disease risk factors. Also, no differences occurred regarding CRP level (group A vs. B: hsCRP 10.8±1.8 mg/l vs. 8.2±2.8 mg/l; p=NS) and TIMI Risk Score (group A vs. B: 4.3±0.71 vs. 4.37±0.79; p=NS). During long-term follow-up the incidence of MI (9.25% vs. 1.2%, p=0.03), composite endpoint: death + MI (14.8% vs. 2.32%, p=0.013) and death + MI + re PCI (25.9% vs. 8.1%, p=0.006) was significantly higher in group A than group B. Conclusions: Administration of high-dose statin in NSTE ACS patients before PCI was associated with significant reduction of MACE in long-term follow-up. This effect was observed despite the same therapy given after PCI.
Get Citation

Keywords

acute coronary syndrome; statin; inflammation; coronary angioplasty

About this article
Title

Original article
Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 64, No 12 (2006)

Pages

1357-1362

Published online

2006-12-21

Bibliographic record

Kardiol Pol 2006;64(12):1357-1362.

Keywords

acute coronary syndrome
statin
inflammation
coronary angioplasty

Authors

Michał Chyrchel
Tomasz Rakowski
Łukasz Rzeszutko
Jacek Legutko
Artur Dziewierz
Jacek S. Dubiel
Dariusz Dudek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl